Results
Participants and baseline characteristics
A
Seventy-four patients (74 eyes) with traumatic endophthalmitis were included. Mean age was 53.5 ± 18.3 years (range, 1.6–91.5), and most were male (69/74, 93.2%) from rural background (67/74, 90.5%)
(Table
1).
Table 1
Baseline Demographic and Injury Characteristics in 74 Eyes With Traumatic Endophthalmitis
|
Variable
|
n (%) or Mean ± SD (range)
|
|
Age (years)
|
53.5 ± 18.3 (1.6–91.5)
|
|
Sex – male
|
69 (93.2%)
|
|
Sex – female
|
5 (6.8%)
|
|
Rural background
|
67 (90.5%)
|
|
Penetrating trauma
|
71 (95.9%)
|
|
• With IOFB
|
34 (45.9%)
|
|
• Without IOFB
|
37 (50.0%)
|
|
Blunt / non‑penetrating trauma
|
3 (4.1%)
|
|
Corneal wound
|
45 (60.8%)
|
|
Scleral wound
|
9 (12.2%)
|
|
Combined corneal–scleral wound
|
2 (2.7%)
|
|
Wound location not specified
|
20 (27.0%)
|
Injury characteristics
Penetrating trauma occurred in 71/74 cases (95.9%), whereas 3/74 (4.1%) were blunt injuries. IOFB was identified in 34/74 eyes (45.9%). Wound location was corneal in 45/74 eyes (60.8%), scleral in 9/74 (12.2%), combined corneal–scleral in 2/74 (2.7%), and not specified in 20/74 (27.0%). Metallic traumatizing material were present in 31/74 injuries (41.9%) and vegetal/organic materials in 18/74 (24.3%); the remaining cases involved inert or unknown materials (Table 1). The mean time from trauma to diagnosis was 1.2 ± 1.6 days (range, 0–8).
Anatomical complications at presentation
Retinal detachment (RD) was present in 23/74 eyes (31.1%). Lens involvement (traumatic cataract, dislocation, aphakia, or capsular opacity) occurred in 19/74 eyes (25.7%). Corneal alteration (edema, keratitis, or melting) was observed in 24/74 (32.4%). Hypopyon was present in 41/74 cases (55.4%) (Table 2).
Table 2
Clinical Complications at Presentation in 74 Eyes With Traumatic Endophthalmitis
|
Complication
|
n (%)
|
|
Retinal detachment
|
23 (31.1%)
|
|
Lens involvement (traumatic cataract, aphakia, or dislocation)
|
19 (25.7%)
|
|
Corneal alteration (edema, keratitis, or corneal melt)
|
24 (32.4%)
|
|
Hypopyon
|
41 (55.4%)
|
Microbiology and antimicrobial susceptibility
Cultures were positive in 43/74 cases (58.1%). Among culture-positive cases, 86.0% of isolates were bacterial (37/43) and 16.3% were fungal (7/43). Of note, 11.6% cases (5/43) were polymicrobial; 4/43 involved multiple bacteria and 1/43 included both bacteria and fungi (Absidia sp., Staphylococcus warneri and Staphylococcus epidermidis). The most frequent pathogens were Staphylococcus epidermidis (14/74, 18.9%), Staphylococcus aureus (4/74, 5.4%), Bacillus cereus (4/74, 5.4%), and Streptococcus (7/74, 9.5%). Among fungi, Fusarium oxysporum predominated (3/74, 4.1%) (Table 3). Culture positivity was higher in vitreous samples (63.9%) than aqueous humor samples (37.9%).
A
Table 3
Microbiologic Spectrum in 74 Eyes With Traumatic Endophthalmitis
|
Pathogen
|
n (%) of total eyes (N = 74)
|
|
Any positive culture
|
43 (58.1%)
|
|
GRAM- POSITIVE BACTERIA
|
40 (54.1%)
|
|
• Staphylococcus epidermidis
|
14 (18.9%)
|
|
• Other coagulase-negative Staphylococci (S. lugdunensis, S. hominis, S. warneri, S. cohnii, S. capitis)
|
6 (8.1%)
|
|
• Staphylococcus aureus
|
4 (5.4%)
|
|
• Streptococcus agalactiae
|
4 (5.4%)
|
|
• Oral viridans Streptococci (Streptococcus parasanguis, Streptococcus mitis, Viridans Group Streptococcus)
|
3 (4.1%)
|
|
• Bacillus cereus
|
4 (5.4%)
|
|
• Enterococcus faecalis
|
2 (2.7%)
|
|
• Micrococcus sp.
|
1 (1.4%)
|
|
• Clostridium sp.
|
1 (1.4%)
|
|
• Cutibacterium acnes
|
1 (1.4%)
|
|
GRAM- NEGATIVE BACTERIA
|
3 (4.1%)
|
|
• Proteus mirabilis
|
1 (1.4%)
|
|
• Escherichia coli
|
1 (1.4%)
|
|
• Citrobacter freundii
|
1 (1.4%)
|
|
FUNGI
|
7 (9.5%)
|
|
• Fusarium oxysporum
|
3 (4.1%)
|
|
• Scedosporium apiospermum
|
2 (2.7%)
|
|
• Candida parapsilosis
|
1 (1.4%)
|
|
• Absidia sp. (Lictheimia)
|
1 (1.4%)
|
|
POLYMICROBIAL
|
5 (6.8%)
|
Bacterial isolates showed frequent resistance to macrolides and lincosamides. In Staphylococcus spp., resistance to erythromycin and clindamycin was 28.3% and 10.9%, respectively; resistance to gentamicin was 10.9% and to oxacillin 6.5%. In Streptococcus spp., resistance to penicillin, ampicillin, and amoxicillin–clavulanate was 13.0%, 8.7%, and 4.3%, respectively. Although Gram-negative organisms were less common, multidrug-resistant isolates were identified, including Citrobacter freundii and Proteus mirabilis. Quinolone resistance was low in our series (2.2% to ciprofloxacin; none to moxifloxacin). Aminoglycoside resistance was 10.9%. One Fusarium oxysporum isolate showed broad resistance across polyenes, azoles, and echinocandins; the remaining fungal isolates were susceptible. (Table 3).
Treatment
Initial management included PPV in 48/74 eyes (64.9%). Intravitreal antimicrobials were administered in 52/74 eyes (70.3%), with 20/74 (27.0%) receiving two or more injections. Vancomycin plus ceftazidime was the most common intravitreal regimen; intravitreal voriconazole or dexamethasone were used selectively. Systemic antibiotics were administered to 61/74 patients (82.4%), and systemic corticosteroids to 22/74 (29.7%). Hospital admission was required in 55/74 cases (74.3%), with a mean stay of 7.8 ± 5.7 days (median, 7). The first intravitreal injection occurred at 0.3 ± 1.2 days from diagnosis (Table 4).
Table 4
Treatment Modalities in 74 Eyes With Traumatic Endophthalmiti
|
Intervention
|
n (%) of eyes (N = 74)
|
|
Pars plana vitrectomy (PPV)
|
48 (64.9%)
|
|
Intravitreal antimicrobial injections (IVI)
|
52 (70.3%)
|
|
≥ 2 IVI
|
20 (27.0%)
|
|
Time from diagnosis to first IVI
|
0.3 ± 1.2 (mean ± SD, days)
|
|
Systemic antimicrobial treatment
|
61 (82.4%)
|
|
Systemic corticosteroids
|
22 (29.7%)
|
|
Hospital admission
|
55 (74.3%)
|
Visual and anatomic outcomes
Baseline BCVA was 2.10 ± 0.72 logMAR (median, 2.3), improving to 1.06 ± 1.26 logMAR at final follow-up. Overall, 43.2% achieved final BCVA ≤ 1.0 logMAR and anatomical loss (phthisis bulbi or evisceration) occurred in 18 eyes (24.3%) (Table 5). Evisceration occurred in 12/74 eyes (16.2%).
Table 5
Visual and Anatomical Outcomes in 74 Eyes With Traumatic Endophthalmitis
|
Outcome
|
n (%) or Mean ± SD (median)
|
|
Baseline BCVA (logMAR)
|
2.10 ± 0.72 (2.3)
|
|
Final BCVA (logMAR)
|
1.06 ± 1.26 (1.6)
|
|
BCVA improvement from baseline
|
33 (41.2%)
|
|
Final BCVA ≤ 1.0 logMAR
|
32 (43.2%)
|
|
Final BCVA > 1.0 logMAR
|
31 (41.9%)
|
|
Severe visual outcomes: LP
|
7 (9.5%)
|
|
Severe visual outcomes: HM
|
4 (5.4%)
|
|
Severe visual outcomes: NLP
|
15 (20.3%)
|
|
Final BCVA not registered
|
11 (14.9%)
|
|
Evisceration
|
12 (16.2%)
|
|
Phthisis bulbi
|
6 (8.1%)
|
|
Globe preservation
|
56 (75.7%)
|
Factors associated with poor visual prognosis
On univariate analysis, baseline BCVA was the only significant predictor of poor final BCVA (≥ 1.0 logMAR). Thresholds of 2.3 logMAR and 2.0 logMAR yielded ORs of 8.59 (95% CI 1.85–39.79; p = 0.004) and 7.15 (95% CI 1.53–33.45; p = 0.010), respectively.
IOFB presence, IOFB material, wound location, hypopyon, anterior chamber fibrin, flat anterior chamber, lens involvement, age ≥ 70 years, fungal vs bacterial etiology, and Gram-positive vs Gram-negative organisms were not significantly associated with outcome (Table 6). Since only baseline BCVA demonstrated a significant association in univariate analysis, a multivariable model was not constructed. Though it was not statistically significant, we observed final BCVA (median) varied by pathogen: 2.00 logMAR for Gram positives, 2.50 logMAR for Gram negatives, and 1.25 logMAR for Fungi (Table 6). Polymicrobial infections had uniformly poor outcomes (final BCVA 3.0 logMAR) (Table 6). Final BCVA (median) also varied by the nature of the traumatizing material: 3.00 logMAR for blunt organic injuries, which caused keratitis with poor evolution, 0.80 logMAR for metallic penetrating injuries with IOFB, and 0.30 logMAR for penetrating organic injuries without IOFB (Table 7).
Table 6
Final BCVA by Microorganism group
|
Microbiological Group
|
n
|
Final BCVA (logMAR), median (IQR)
|
|
Gram positives
|
40
|
2.00 (0.40–2.80)
|
|
Gram negatives
|
3
|
2.50 (2.25–2.75)
|
|
Fungi
|
7
|
1.25 (0.20–2.83)
|
|
Polymicrobial
|
5
|
3.00 (2.00–3.00)
|
|
Negative culture / Not registered
|
31
|
0.40 (0.10–2.30)
|
| Gram positives included Staphylococcus spp. (S. epidermidis, S. aureus, S. hominis, S. capitis, S. cohnii, S. lugdunensis, S. warneri), Streptococcus spp. (S. viridans, S. mitis, S. parasanguis, S. agalactiae), Bacillus spp., Enterococcus faecalis, Micrococcus spp. and Cutibacterium acnes. |
| Gram negatives included Escherichia coli, Proteus mirabilis and Citrobacter freundii. |
| Fungi included Fusarium oxysporum, Candida parapsilosis, Scedosporium apiospermum and Absidia sp. |
| Polymicrobial was defined as the isolation of ≥ 2 microorganisms in the same episode. |
Table 7
Final BCVA by Traumatizing Material
|
Trauma
|
IOFB
|
Nature (grouped)
|
n
|
Final BCVA (logMAR), median (IQR)
|
|
Blunt
|
No
|
Vegetal
|
3
|
3.00 (2.50–3.00)
|
|
Penetrating
|
Yes
|
Metallic
|
25
|
0.80 (0.15–2.30)
|
|
Vegetal
|
2
|
1.00 (—)
|
|
Other / Unknown
|
8
|
2.30 (0.30–3.00)
|
|
No
|
Metallic
|
6
|
0.20 (0.10–3.00)
|
|
Vegetal
|
13
|
0.30 (0.20–3.00)
|
|
Other / Unknown
|
17
|
2.80 (0.00–3.00)
|
Treatment-specific outcomes
Poor final BCVA (≥ 1.0 logMAR) occurred in 58.8% of eyes receiving intravitreal therapy vs 40.0% of those without intravitreal therapy. PPV was not significantly associated with final BCVA (49.0% vs 34.5%; p = 0.211). Similar outcomes were observed regardless of systemic antibiotic or corticosteroid use (Table 4).
Discussion
The study population was predominantly rural, reflecting the socioeconomic context of Galicia and Asturias, where agricultural, livestock, and industrial activities are common and inherently increase the risk of ocular trauma from metallic and organic debris. The northwest of Spain has a temperate oceanic climate characterized by mild temperatures, high humidity, and frequent rainfall throughout much of the year. These environmental conditions—together with rural occupational exposures—may shape the local microbiological landscape of traumatic endophthalmitis, with a potentially higher burden of soil- and plant-associated organisms compared with drier or urban regions. Male predominance observed in our study, associated with a wide range of ages, is consistent with previous reports and appears to be related to the greater exposure of males to higher-risk work environments (industrial, agricultural, or involving the use of tools) [4, 5].
The nature of the trauma played a critical role in the etiology of the endophthalmitis cases analyzed.
A
In our study, IOFB was identified in 45.9% of cases, with metallic objects being the most frequently implicated (41.9%), followed by organic materials in 24.3%. Zhuang et al. reported comparable rates of IOFB identification in cases of traumatic endophthalmitis (33.9%) [
6]. Other authors, consistent with our observations, have also documented a predominance of metallic IOFBs among those identified [
7,
8]. Nonetheless, it is important to emphasize that although the presence of an IOFB substantially increases both severity and infection risk, it is not a prerequisite for the development of post-traumatic endophthalmitis.
Functional recovery following traumatic endophthalmitis remained markedly limited. Although most eyes maintained anatomical integrity, only 43.2% achieved a final BCVA ≤ 1.0 logMAR, underscoring the substantial visual morbidity associated with these injuries. These findings are consistent with aggregated evidence from large cohorts assessing prognostic determinants and surgical timing in open-globe trauma [1, 2]. The ocular manifestations documented in our study align with previous reports and are indicative of a marked and often abrupt inflammatory response [4, 5]. Corneal perforation, identified in 60.8% of cases, was most strongly associated with poor baseline VA and the subsequent need for complex, highly invasive reconstructive procedures.
In our series, baseline VA was the only variable significantly associated with poor visual outcome, while culture positivity, IOFB, and RD showed trends aligned with published literature but did not reach statistical significance. The unadjusted association between intravitreal therapy and poorer visual outcomes likely reflects confounding by indication: eyes with greater baseline severity (e.g., dense vitritis, IOFB, or media opacity) were preferentially treated more intensively; therefore, this correlation should not be inferred as causal [2–3, 9–16]. Prospective capture of injection number and timing, alongside standardized severity metrics and multivariable methods to adjust for baseline imbalances, would help clarify this relationship in future studies.
A
Microbiologically, Gram-positive bacteria predominated, accounting for 93.0% of positive cultures (40/43), with
Staphylococcus species being the most frequently isolated organisms (55.8% of positive cultures, 24/43). Among these, coagulase-negative
Staphylococcus represented 46.5% of positive samples (20/43).
Bacillus cereus constituted 9.3% of positive samples (4/43) and has traditionally been associated with rapidly progressive post-traumatic presentations and infections related to intraocular foreign bodies (IOFBs), particularly in reports from rural or industrial settings where such microorganisms are common contaminants of open-globe injuries [
8].
This profile supports empirical intravitreal coverage targeting Gram-positive and Gram-negative organisms, in line with national guidance from the Spanish Vitreo-Retinal Society (SERV), which advocates empirical intravitreal treatment combining vancomycin with a third-generation cephalosporin (or equivalent Gram-negative coverage), and aligns with recently published reviews on traumatic endophthalmitis [3–6].
Fungal infections were less common in our series (16.3% of positive cultures, 7/43) but remained clinically relevant—particularly in injuries involving vegetative material—consistent with published traumatic series [6, 10]. Nevertheless, they occurred at a slightly higher rate than that reported in other series (5%–15%) [7, 8]. This increased incidence may be related to local climatic conditions—specifically a humid and temperate environment—as well as greater agricultural and livestock activity in the region, factors that heighten the risk of trauma involving vegetative material, a well-recognized vector for fungal inoculation.
Most of the microorganisms isolated in our series demonstrated good susceptibility to the antimicrobial regimens commonly used for empirical intravitreal therapy. However, over the course of more than 20 years, some cases exhibited resistance patterns, particularly to macrolides and lincosamides among Staphylococcus, and although Gram-negative organisms were less common, multidrug-resistant isolates were identified during this period, especially Citrobacter freundii and Proteus mirabilis. These findings underscore the need to adjust the therapeutic regimen once antimicrobial susceptibility results became available. Given that initial treatment in most cases of endophthalmitis is administered empirically, the availability of local antimicrobial susceptibility data is essential to guide the selection of first-line therapy and optimize clinical outcomes.
A
Regarding prophylaxis after open-globe injury, recent meta-analytic data shows no benefit to extending systemic antibiotics beyond 24 hours and no superiority of intravenous or intraocular routes over oral administration; ciprofloxacin monotherapy underperforms versus vancomycin plus a third-generation cephalosporin [
16]. These results support concise, risk-adapted prophylaxis—particularly in patients with IOFB, rural injuries, or lens rupture—and reinforce our cohort’s empirical Gram-positive/Gram-negative approach, in harmony with SERV recommendations [
1–
3,
6,
16].
Because management is initiated empirically, rapid diagnostics can complement culture-based testing. Polymerase chain reaction (PCR) can refine early treatment decisions and support diagnosis when initial cultures are negative [17]. Among host-response biomarkers, vitreous soluble Triggering Receptor Expressed on Myeloid cells-1 (sTREM-1) may help discriminate infectious from non-infectious presentations; elevations have been reported in both culture-positive and culture-negative traumatic cases, supporting escalation when clinical suspicion remains high despite negative cultures [18].
The traditional Endophthalmitis Vitrectomy Study (EVS) paradigm is frequently challenged in the context of traumatic endophthalmitis. The role and timing of PPV should be individualized. In our series, PPV was performed early in 64.9% of cases and was not independently associated with worse visual outcomes. When IOFB, dense vitritis, or media opacity are present, early PPV facilitates source control, direct sampling, and removal of necrotic/toxic material—though definitions of “early” vary across studies [1, 9–11]. Notably, PPV serves both therapeutic and diagnostic purposes by enabling removal of inflamed and infected vitreous, enhancing intravitreal antibiotic penetration, and providing samples for culture. In eyes with total media opacity where a temporary keratoprosthesis is not feasible, ultrasound-guided PPV (USG‑PPV) can enable safer debulking under intraoperative imaging [19]. Recently, the complementary use of intravitreal injections or low-concentration diluted povidone–iodine irrigation (0.025%–1.25%) has been recommended, as it has demonstrated bactericidal, fungicidal, and virucidal activity in infections associated with intraocular foreign bodies, without inducing inflammation or retinal toxicity; however, the overall quality of evidence remains limited [20, 21].
Broader epidemiologic experience similarly emphasizes the ongoing burden of trauma-related endophthalmitis and the importance of coordinated regional care networks, consistent with our multicenter experience in Asturias and Galicia [3, 12–15].
Strengths of this study include its multicenter design, standardized VA conversion, and comprehensive capture of microbiology, treatment, and outcomes across two decades. Limitations inherent to retrospective analyses include potential selection/referral bias, incomplete timing data, and residual confounding by indication (notably for intravitreal therapy and PPV). Inter-hospital variability in practice, small fungal and Gram-negative subgroups, and possible misclassification of IOFB material may limit generalizability. Future prospective studies should incorporate prespecified, penalized multivariable analyses, standardized time-to-intervention metrics, and systematic handling of missing data.